What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine.
Adrian S WaggSender HerschornMartin CarlssonMireille FernetMatthias OelkePublished in: Neurourology and urodynamics (2021)
These data provide clinicians with information from which they may usefully communicate the likelihood of symptom resolution in response to pharmacotherapy for OAB and answer a key clinical question posed by many care providers. Roughly ⅓ of fesoterodine treated patients reported a 50% reduction urgency and ¾ reported 50% resolution of incontinence at 12 weeks. Total resolution of all symptoms was seldom achieved.
Keyphrases
- end stage renal disease
- palliative care
- healthcare
- newly diagnosed
- chronic kidney disease
- single molecule
- ejection fraction
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- social media
- pain management
- physical activity
- depressive symptoms
- machine learning
- patient reported outcomes
- big data
- sleep quality
- urinary incontinence